Search research articles
Contact Us
Filters
Showing results (921-930 of 942) with videos related to
Page
of 95
Sort By:
Optics Express
|
August 20, 2010
Time-resolved pump-probe experiments at the LCLS
James M Glownia, J Cryan, J Andreasson, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Anmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
Matthew M Weiss, Thomas A Dineen, Isaac E Marx, et al.
JCI Insight
|
December 7, 2018
FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia
Irini Manoli, Justin R Sysol, Madeline W Epping, et al.
Neurology. Genetics
|
April 28, 2020
Mitochondrial diseases in North America: An analysis of the NAMDC Registry
Emanuele Barca, Yuelin Long, Victoria Cooley, et al.
American Journal of Human Genetics
|
September 26, 2017
Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies
René G Feichtinger, Monika Oláhová, Yoshihito Kishita, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Science Advances
|
November 21, 2025
Visualizing the strong field-induced molecular breakup of C<sub>60</sub> via x-ray diffraction
Kirsten Schnorr, Sven Augustin, Ulf Saalmann, et al.
Journal of Medicinal Chemistry
|
March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Page
of 95
Search research articles
Search
Showing results (921-930 of 942) with videos related to
Sort By:
Page
of 95
Optics Express
|
August 20, 2010
Time-resolved pump-probe experiments at the LCLS
James M Glownia, J Cryan, J Andreasson, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Anmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
Matthew M Weiss, Thomas A Dineen, Isaac E Marx, et al.
JCI Insight
|
December 7, 2018
FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia
Irini Manoli, Justin R Sysol, Madeline W Epping, et al.
Neurology. Genetics
|
April 28, 2020
Mitochondrial diseases in North America: An analysis of the NAMDC Registry
Emanuele Barca, Yuelin Long, Victoria Cooley, et al.
American Journal of Human Genetics
|
September 26, 2017
Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies
René G Feichtinger, Monika Oláhová, Yoshihito Kishita, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Science Advances
|
November 21, 2025
Visualizing the strong field-induced molecular breakup of C<sub>60</sub> via x-ray diffraction
Kirsten Schnorr, Sven Augustin, Ulf Saalmann, et al.
Journal of Medicinal Chemistry
|
March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Page
of 95